Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

[TET2 and DLK1 gene expression and their clinical significance in bone marrow CD(3)(+) T cells of patients with myelodysplastic syndrome].

Zhang W, Fu R, Wang HQ, Li LJ, Yue LZ, Liu H, Qu W, Liang Y, Wang GJ, Wang XM, Wu YH, Liu H, Song J, Guan J, Xing LM, Shao ZH.

Zhonghua Nei Ke Za Zhi. 2012 Jul;51(7):543-6. Chinese.

PMID:
22943828
2.

[Gene expression in patients with myelodysplastic syndrome].

Chen BA, Zhang B, Gao C, Gao F, Xia GH, Shao ZY, Ding JH, Zhao G, Chen J, Wang J, Song HH, Bao W, Zhong YJ, Pei XP, Wang F, Gu ZZ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Jun;18(3):666-70. Chinese.

PMID:
20561424
3.

Down-regulation of TET2 in CD3⁺ and CD34⁺ cells of myelodysplastic syndromes and enhances CD34⁺ cells proliferation.

Zhang W, Shao Z, Fu R, Wang H, Li L, Liu H.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):10840-6. eCollection 2015.

4.

Expression of DLK1 Gene in the Bone Marrow Cells of Patients with Myelodysplastic Syndromes and Its Clinical Significance.

Yue LZ, Fu R, Wang HQ, Li LJ, Ruan EB, Wang GJ, Qu W, Liang Y, Guan J, Wu YH, Liu H, Song J, Wang XM, Xing LM, Shao ZH.

Cancer Biol Med. 2012 Sep;9(3):188-91. doi: 10.7497/j.issn.2095-3941.2012.03.006.

5.

TET2 Expression in Bone Marrow Mononuclear Cells of Patients with Myelodysplastic Syndromes and Its Clinical Significances.

Zhang W, Shao ZH, Fu R, Wang HQ, Li LJ, Wang J, Qu W, Liang Y, Wang GJ, Wang XM, Wu Y, Liu H, Song J, Guan J, Xing LM.

Cancer Biol Med. 2012 Mar;9(1):34-7. doi: 10.3969/j.issn.2095-3941.2012.01.006.

6.

Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value.

Smith AE, Mohamedali AM, Kulasekararaj A, Lim Z, Gäken J, Lea NC, Przychodzen B, Mian SA, Nasser EE, Shooter C, Westwood NB, Strupp C, Gattermann N, Maciejewski JP, Germing U, Mufti GJ.

Blood. 2010 Nov 11;116(19):3923-32. doi: 10.1182/blood-2010-03-274704. Epub 2010 Aug 6.

7.

Interleukin-17 enhances the production of interferon-γ and tumour necrosis factor-α by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes.

Zhang Z, Li X, Guo J, Xu F, He Q, Zhao Y, Yang Y, Gu S, Zhang Y, Wu L, Chang C.

Eur J Haematol. 2013 May;90(5):375-84. doi: 10.1111/ejh.12074. Epub 2013 Mar 1.

PMID:
23331180
8.

The effects of increased expression of DLK1 gene on the pathogenesis of myelodysplastic syndromes.

Ma X, Zhang Y, Yang L, Xu Z, Xiao Z.

Clin Lymphoma Myeloma Leuk. 2012 Aug;12(4):261-8. doi: 10.1016/j.clml.2012.03.002. Epub 2012 Apr 17.

PMID:
22513084
9.

Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes.

Sawanobori M, Yamaguchi S, Hasegawa M, Inoue M, Suzuki K, Kamiyama R, Hirokawa K, Kitagawa M.

Leuk Res. 2003 Jul;27(7):583-91.

PMID:
12681357
10.

CXXC4 mRNA levels are associated with clinicopathological parameters and survival of myelodysplastic syndrome patients.

Li S, Fan R, Zhao XL, Wang XQ.

Leuk Res. 2014 Sep;38(9):1072-8. doi: 10.1016/j.leukres.2014.07.002. Epub 2014 Jul 14.

PMID:
25085016
11.
12.

In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome.

Zheng Z, Qianqiao Z, Qi H, Feng X, Chunkang C, Xiao L.

Exp Hematol. 2010 Aug;38(8):677-84. doi: 10.1016/j.exphem.2010.04.002. Epub 2010 Apr 13.

PMID:
20394797
13.

[mRNA expression of notch ligand-delta-like-1 and jagged-1 in mesenchymal stem cells of MDS patients].

Fei CM, Gu SC, Zhao YS, Guo J, Li X, Chang CK.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Dec;22(6):1656-60. doi: 10.7534/j.issn.1009-2137.2014.06.029. Chinese.

PMID:
25543492
14.

Burden of abnormal hematopoietic clone in patients with myelodysplastic syndromes.

Wang HQ, Shao ZH, Shi J, Cao YR, Liu H, Bai J, Tu MF, Xing LM, Cui ZZ, Liu SH, Sun J, Jia HR, Yang TY.

Chin Med Sci J. 2006 Jun;21(2):99-103.

PMID:
16845796
15.

Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.

Pülhorn H, Herrmann M, Harms H, Jung A, Baumann I.

Histopathology. 2012 Aug;61(2):200-11. doi: 10.1111/j.1365-2559.2012.04209.x. Epub 2012 Jun 13.

PMID:
22690734
16.

[mRNA expression of telomere protection protein TIN2 and POT1 in bone marrow of patients with myelodysplastic syndrome].

Ye F, He YM, Li GX, Wang LN, Jia N, Ma RX, Ma YP.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Feb;21(1):110-5. doi: 10.7534/j.issn.1009-2137.2013.01.023. Chinese.

PMID:
23484702
17.

[Differentiation and expression of membrane hemopoietic cytokine receptors on CD34+ bone marrow cells in patients with myelodysplastic syndromes].

Li LJ, Fu R, Wang HQ, Yue LZ, Liu H, Wang J, Wang HL, Ruan EB, Qu W, Liang Y, Wang GJ, Wang XM, Liu H, Song J, Wu YH, Xing LM, Guan J, Shao ZH.

Zhonghua Yi Xue Za Zhi. 2011 Jan 25;91(4):234-8. Chinese.

PMID:
21418866
18.

Abnormal expression of C3ORF9 gene in patients with myelodysplastic syndromes.

Karadonta AV, Alexandrakis MG, Kourelis TV, Manola A, Garlemou K, Stathakis NE, Kyriakou D.

Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3):787-93.

PMID:
19822096
19.

[Abnormalities of CD34+ cells differentiation and bone marrow cell cycle in myelodysplastic syndrome].

Li LJ, Fu R, Shao ZH, Wang HQ, Yue LZ, Ruan EB, Liu H, Wang J, Wang HL.

Zhonghua Nei Ke Za Zhi. 2010 Nov;49(11):963-6. Chinese.

PMID:
21211213
20.

Ten-eleven-translocation 2 (TET2) is downregulated in myelodysplastic syndromes.

Scopim-Ribeiro R, Machado-Neto JA, Campos Pde M, Silva CA, Favaro P, Lorand-Metze I, Costa FF, Saad ST, Traina F.

Eur J Haematol. 2015 May;94(5):413-8. doi: 10.1111/ejh.12445. Epub 2014 Oct 1.

PMID:
25200248
Items per page

Supplemental Content

Write to the Help Desk